Vincent Trebosc

806 total citations
15 papers, 465 citations indexed

About

Vincent Trebosc is a scholar working on Molecular Medicine, Molecular Biology and Epidemiology. According to data from OpenAlex, Vincent Trebosc has authored 15 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Medicine, 6 papers in Molecular Biology and 5 papers in Epidemiology. Recurrent topics in Vincent Trebosc's work include Antibiotic Resistance in Bacteria (12 papers), Pneumocystis jirovecii pneumonia detection and treatment (4 papers) and Tuberculosis Research and Epidemiology (3 papers). Vincent Trebosc is often cited by papers focused on Antibiotic Resistance in Bacteria (12 papers), Pneumocystis jirovecii pneumonia detection and treatment (4 papers) and Tuberculosis Research and Epidemiology (3 papers). Vincent Trebosc collaborates with scholars based in Switzerland, France and United States. Vincent Trebosc's co-authors include Christian Kemmer, Sergio Lociuro, Marc Gitzinger, Philip Rosenstiel, Camilo Barbosa, Gunther Jansen, Hinrich Schulenburg, Robert Beardmore, Michel Pieren and Dirk Bumann and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Molecular Biology and Evolution and Frontiers in Microbiology.

In The Last Decade

Vincent Trebosc

15 papers receiving 460 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vincent Trebosc Switzerland 9 308 184 105 103 81 15 465
Akshay Sabnis United Kingdom 7 269 0.9× 195 1.1× 80 0.8× 72 0.7× 80 1.0× 11 465
Renaud Chollet France 11 315 1.0× 144 0.8× 132 1.3× 108 1.0× 110 1.4× 16 486
John Goldman United States 6 236 0.8× 174 0.9× 65 0.6× 129 1.3× 93 1.1× 11 447
Jon W. Weeks United States 12 405 1.3× 180 1.0× 94 0.9× 177 1.7× 116 1.4× 16 556
Gabriel Torrens Spain 13 368 1.2× 250 1.4× 118 1.1× 64 0.6× 121 1.5× 31 571
Martina Pasqua Italy 13 236 0.8× 209 1.1× 175 1.7× 113 1.1× 45 0.6× 23 525
Roderich Roemhild Germany 9 180 0.6× 159 0.9× 45 0.4× 165 1.6× 67 0.8× 9 419
Alina D. Gutu United States 9 228 0.7× 256 1.4× 53 0.5× 151 1.5× 57 0.7× 9 456
Arnaud Bolard France 6 363 1.2× 164 0.9× 79 0.8× 71 0.7× 111 1.4× 7 457

Countries citing papers authored by Vincent Trebosc

Since Specialization
Citations

This map shows the geographic impact of Vincent Trebosc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent Trebosc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent Trebosc more than expected).

Fields of papers citing papers by Vincent Trebosc

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vincent Trebosc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent Trebosc. The network helps show where Vincent Trebosc may publish in the future.

Co-authorship network of co-authors of Vincent Trebosc

This figure shows the co-authorship network connecting the top 25 collaborators of Vincent Trebosc. A scholar is included among the top collaborators of Vincent Trebosc based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vincent Trebosc. Vincent Trebosc is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Terlouw, Barbara R., Chao Du, Joost Willemse, et al.. (2024). Discovery and Derivatization of Tridecaptin Antibiotics with Altered Host Specificity and Enhanced Bioactivity. ACS Chemical Biology. 19(5). 1106–1115. 3 indexed citations
2.
Janssen, Axel B., Vincent de Bakker, Rieza Aprianto, et al.. (2023). Klebsiella pneumoniae OmpR facilitates lung infection through transcriptional regulation of key virulence factors. Microbiology Spectrum. 12(1). e0396623–e0396623. 2 indexed citations
3.
Bourotte, Marilyne, Marc Gitzinger, Christian Kemmer, et al.. (2023). Structure-activity relationships of actively FhuE transported rifabutin derivatives with potent activity against Acinetobacter baumannii. European Journal of Medicinal Chemistry. 252. 115257–115257. 4 indexed citations
4.
Trebosc, Vincent, Mohit Narwal, Marilyne Bourotte, et al.. (2022). Targeting virulence regulation to disarm Acinetobacter baumannii pathogenesis. Virulence. 13(1). 1868–1883. 7 indexed citations
5.
Trebosc, Vincent, Marc Gitzinger, Benoît Déprez, et al.. (2022). Design and synthesis of water-soluble prodrugs of rifabutin for intraveneous administration. European Journal of Medicinal Chemistry. 238. 114515–114515. 6 indexed citations
6.
Trebosc, Vincent, Marc Gitzinger, Benoît Déprez, et al.. (2022). Design and Synthesis of Water-Soluble Prodrugs of Rifabutin for Intraveneous Administration. SSRN Electronic Journal. 1 indexed citations
7.
Sivignon, Adeline, Michel Pieren, Marc Gitzinger, et al.. (2021). The Role of OmpR in Bile Tolerance and Pathogenesis of Adherent-Invasive Escherichia coli. Frontiers in Microbiology. 12. 684473–684473. 12 indexed citations
8.
Trebosc, Vincent, Christian Kemmer, Sergio Lociuro, Marc Gitzinger, & Glenn E. Dale. (2021). Rifabutin for infusion (BV100) for the treatment of severe carbapenem-resistant Acinetobacter baumannii infections. Drug Discovery Today. 26(9). 2099–2104. 15 indexed citations
9.
Luna, Brian, Vincent Trebosc, Malina A. Bakowski, et al.. (2020). A nutrient-limited screen unmasks rifabutin hyperactivity for extensively drug-resistant Acinetobacter baumannii. Nature Microbiology. 5(9). 1134–1143. 53 indexed citations
10.
Trebosc, Vincent, Marilyne Bourotte, Marc Gitzinger, et al.. (2020). In vitroactivity of rifabutin against 293 contemporary carbapenem-resistantAcinetobacter baumanniiclinical isolates and characterization of rifabutin mode of action and resistance mechanisms. Journal of Antimicrobial Chemotherapy. 75(12). 3552–3562. 28 indexed citations
11.
Cunrath, Olivier, Dominik M. Meinel, Joseph Fanous, et al.. (2019). Quantitative contribution of efflux to multi-drug resistance of clinical Escherichia coli and Pseudomonas aeruginosa strains. EBioMedicine. 41. 479–487. 31 indexed citations
12.
Trebosc, Vincent, Marcus Tötzl, Michel Pieren, et al.. (2019). Dissecting Colistin Resistance Mechanisms in Extensively Drug-Resistant Acinetobacter baumannii Clinical Isolates. mBio. 10(4). 94 indexed citations
13.
Barbosa, Camilo, Vincent Trebosc, Christian Kemmer, et al.. (2017). Alternative Evolutionary Paths to Bacterial Antibiotic Resistance Cause Distinct Collateral Effects. Molecular Biology and Evolution. 34(9). 2229–2244. 116 indexed citations
14.
Trebosc, Vincent, Pablo Manfredi, Marcus Tötzl, et al.. (2016). A Novel Genome-Editing Platform for Drug-Resistant Acinetobacter baumannii Reveals an AdeR-Unrelated Tigecycline Resistance Mechanism. Antimicrobial Agents and Chemotherapy. 60(12). 7263–7271. 34 indexed citations
15.
Alkım, Ceren, Débora Trichez, Vincent Trebosc, et al.. (2015). Engineering of a Synthetic Metabolic Pathway for the Assimilation of (d)-Xylose into Value-Added Chemicals. ACS Synthetic Biology. 5(7). 607–618. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026